CalciMedica Common Stock Net Income
| CALC Stock | 0.60 0.01 1.64% |
As of the 8th of February, CalciMedica Common shows the Mean Deviation of 6.46, risk adjusted performance of (0.06), and Standard Deviation of 12.39. CalciMedica Common Stock technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
CalciMedica Common's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing CalciMedica Common's valuation are provided below:We have found one hundred twenty available fundamental signals for CalciMedica Common Stock, which can be analyzed and compared to other ratios and to its rivals. Investors should ensure to validate all of CalciMedica Common's prevailing performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road. The current year's Market Cap is expected to grow to about 37.6 M. The current year's Enterprise Value is expected to grow to about 37.1 M This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. | Last Reported | Projected for Next Year | ||
| Net Loss | -15.8 M | -16.5 M | |
| Net Loss | -15.8 M | -16.5 M | |
| Net Loss | -13.1 M | -13.7 M | |
| Net Loss | (1.10) | (1.15) |
CalciMedica | Net Income | Build AI portfolio with CalciMedica Stock |
Analyzing CalciMedica Common's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing CalciMedica Common's current valuation and future prospects.
Latest CalciMedica Common's Net Income Growth Pattern
Below is the plot of the Net Income of CalciMedica Common Stock over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in CalciMedica Common Stock financial statement analysis. It represents the amount of money remaining after all of CalciMedica Common Stock operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is CalciMedica Common's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CalciMedica Common's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (13.7 M) | 10 Years Trend |
|
Net Income |
| Timeline |
CalciMedica Net Income Regression Statistics
| Arithmetic Mean | (26,115,868) | |
| Coefficient Of Variation | (30.53) | |
| Mean Deviation | 5,957,849 | |
| Median | (28,378,000) | |
| Standard Deviation | 7,973,288 | |
| Sample Variance | 63.6T | |
| Range | 29.2M | |
| R-Value | 0.46 | |
| Mean Square Error | 53.7T | |
| R-Squared | 0.21 | |
| Significance | 0.07 | |
| Slope | 720,926 | |
| Total Sum of Squares | 1017.2T |
CalciMedica Net Income History
Other Fundumenentals of CalciMedica Common Stock
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
CalciMedica Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for CalciMedica Common is extremely important. It helps to project a fair market value of CalciMedica Stock properly, considering its historical fundamentals such as Net Income. Since CalciMedica Common's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of CalciMedica Common's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of CalciMedica Common's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Biotechnology sector continue expanding? Could CalciMedica diversify its offerings? Factors like these will boost the valuation of CalciMedica Common. Projected growth potential of CalciMedica fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every CalciMedica Common data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of CalciMedica Common Stock is measured differently than its book value, which is the value of CalciMedica that is recorded on the company's balance sheet. Investors also form their own opinion of CalciMedica Common's value that differs from its market value or its book value, called intrinsic value, which is CalciMedica Common's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because CalciMedica Common's market value can be influenced by many factors that don't directly affect CalciMedica Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between CalciMedica Common's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CalciMedica Common should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, CalciMedica Common's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
CalciMedica Common 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CalciMedica Common's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CalciMedica Common.
| 11/10/2025 |
| 02/08/2026 |
If you would invest 0.00 in CalciMedica Common on November 10, 2025 and sell it all today you would earn a total of 0.00 from holding CalciMedica Common Stock or generate 0.0% return on investment in CalciMedica Common over 90 days. CalciMedica Common is related to or competes with Tvardi Therapeutics, Lantern Pharma, Actinium Pharmaceuticals, Elutia, Reviva Pharmaceuticals, Xilio Development, and PDS Biotechnology. CalciMedica Common is entity of United States More
CalciMedica Common Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CalciMedica Common's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CalciMedica Common Stock upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.1) | |||
| Maximum Drawdown | 105.18 | |||
| Value At Risk | (11.76) | |||
| Potential Upside | 12.74 |
CalciMedica Common Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CalciMedica Common's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CalciMedica Common's standard deviation. In reality, there are many statistical measures that can use CalciMedica Common historical prices to predict the future CalciMedica Common's volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (1.09) | |||
| Total Risk Alpha | (2.35) | |||
| Treynor Ratio | 2.19 |
CalciMedica Common February 8, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | 2.2 | |||
| Mean Deviation | 6.46 | |||
| Coefficient Of Variation | (1,108) | |||
| Standard Deviation | 12.39 | |||
| Variance | 153.56 | |||
| Information Ratio | (0.1) | |||
| Jensen Alpha | (1.09) | |||
| Total Risk Alpha | (2.35) | |||
| Treynor Ratio | 2.19 | |||
| Maximum Drawdown | 105.18 | |||
| Value At Risk | (11.76) | |||
| Potential Upside | 12.74 | |||
| Skewness | (3.10) | |||
| Kurtosis | 20.42 |
CalciMedica Common Stock Backtested Returns
CalciMedica Common Stock secures Sharpe Ratio (or Efficiency) of -0.0963, which signifies that the company had a -0.0963 % return per unit of risk over the last 3 months. CalciMedica Common Stock exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm CalciMedica Common's Risk Adjusted Performance of (0.06), standard deviation of 12.39, and Mean Deviation of 6.46 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.52, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning CalciMedica Common are expected to decrease at a much lower rate. During the bear market, CalciMedica Common is likely to outperform the market. At this point, CalciMedica Common Stock has a negative expected return of -1.23%. Please make sure to confirm CalciMedica Common's treynor ratio, accumulation distribution, price action indicator, as well as the relationship between the potential upside and day median price , to decide if CalciMedica Common Stock performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.75 |
Almost perfect reverse predictability
CalciMedica Common Stock has almost perfect reverse predictability. Overlapping area represents the amount of predictability between CalciMedica Common time series from 10th of November 2025 to 25th of December 2025 and 25th of December 2025 to 8th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CalciMedica Common Stock price movement. The serial correlation of -0.75 indicates that around 75.0% of current CalciMedica Common price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.75 | |
| Spearman Rank Test | -0.83 | |
| Residual Average | 0.0 | |
| Price Variance | 5.16 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
CalciMedica Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, CalciMedica Common Stock reported net income of (13.7 Million). This is 104.01% lower than that of the Biotechnology sector and 119.56% lower than that of the Health Care industry. The net income for all United States stocks is 102.4% higher than that of the company.
CalciMedica Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CalciMedica Common's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CalciMedica Common could also be used in its relative valuation, which is a method of valuing CalciMedica Common by comparing valuation metrics of similar companies.CalciMedica Common is currently under evaluation in net income category among its peers.
CalciMedica Common Current Valuation Drivers
We derive many important indicators used in calculating different scores of CalciMedica Common from analyzing CalciMedica Common's financial statements. These drivers represent accounts that assess CalciMedica Common's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of CalciMedica Common's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 2.8M | 8.8M | 9.0M | 39.8M | 35.8M | 37.6M | |
| Enterprise Value | (30.7M) | (4.5M) | 13.0M | 31.9M | 36.7M | 37.1M |
CalciMedica Fundamentals
| Return On Equity | -5.26 | ||||
| Return On Asset | -1.0 | ||||
| Current Valuation | 3.51 M | ||||
| Shares Outstanding | 14.41 M | ||||
| Shares Owned By Insiders | 23.62 % | ||||
| Shares Owned By Institutions | 55.91 % | ||||
| Number Of Shares Shorted | 80.44 K | ||||
| Price To Book | 6.98 X | ||||
| EBITDA | (24.15 M) | ||||
| Net Income | (13.7 M) | ||||
| Total Debt | 5.38 M | ||||
| Book Value Per Share | (0.02) X | ||||
| Cash Flow From Operations | (21.15 M) | ||||
| Short Ratio | 0.79 X | ||||
| Earnings Per Share | (1.62) X | ||||
| Target Price | 13.67 | ||||
| Number Of Employees | 15 | ||||
| Beta | 0.96 | ||||
| Market Capitalization | 8.65 M | ||||
| Total Asset | 19.79 M | ||||
| Retained Earnings | (159.76 M) | ||||
| Working Capital | 15.98 M | ||||
| Net Asset | 19.79 M |
About CalciMedica Common Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CalciMedica Common Stock's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CalciMedica Common using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CalciMedica Common Stock based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether CalciMedica Common Stock offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CalciMedica Common's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Calcimedica Common Stock Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Calcimedica Common Stock Stock:Check out You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Will Biotechnology sector continue expanding? Could CalciMedica diversify its offerings? Factors like these will boost the valuation of CalciMedica Common. Projected growth potential of CalciMedica fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every CalciMedica Common data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of CalciMedica Common Stock is measured differently than its book value, which is the value of CalciMedica that is recorded on the company's balance sheet. Investors also form their own opinion of CalciMedica Common's value that differs from its market value or its book value, called intrinsic value, which is CalciMedica Common's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because CalciMedica Common's market value can be influenced by many factors that don't directly affect CalciMedica Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between CalciMedica Common's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CalciMedica Common should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, CalciMedica Common's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.